???global.info.a_carregar???
As the CEO of AccelBio, a collaborative laboratory that accelerates the translation of biomedical research into innovative products and services, I lead the strategic vision, external relations, business development, and operational management of the organization. With a PhD in Biomedical Sciences and years of experience as a Technology Transfer Officer at Instituto de Medicina Molecular, I have a proven track record of screening, evaluating, marketing, and licensing new technologies derived from R&D projects in the fields of oncology, neurology, immunology, and infection. I also have extensive experience in promoting research collaborations with pharmaceutical and biotechnology companies, supporting investigator-initiated studies, managing intellectual property, and supporting the creation of start-ups. I am passionate about bridging the gap between academia and industry, fostering innovation and entrepreneurship, and advancing the health and well-being of society. I value collaboration, diversity, and excellence, and I strive to bring these principles to AccelBio and its partners.
Read full resume ↓
Identification

Personal identification

Full name
Bárbara Sofia Lopes Gomes

Citation names

  • Gomes, Bárbara

Author identifiers

Ciência ID
5213-15BD-BF32
ORCID iD
0000-0003-4506-182X

Email addresses

  • barbara.slgomes@gmail.com (Professional)
  • barbaragomes@accelbio.pt (Professional)

Websites

Knowledge fields

  • Engineering and Technology - Chemical Engineering
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism
  • Medical and Health Sciences - Health Sciences
  • Medical and Health Sciences - Health Sciences - Infectious Diseases
  • Medical and Health Sciences - Medical Biotechnology
  • Medical and Health Sciences - Medical Biotechnology

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese (Mother tongue)
Education
Degree Classification
2014/04/01 - 2018/10/12
Concluded
 Biomedical Sciences, specialty Medical Biochemistry (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
""Characterization of enveloped viruses inhibition by 25-hydroxycholesterol at the membrane level"" (THESIS/DISSERTATION)
 Approved with distinctions and honors
2006 - 2011
Concluded
 Pharmaceutical Sciences (Mestrado integrado)
Universidade de Coimbra Faculdade de Farmácia, Portugal
Affiliation

Science

Category
Host institution 		Employer
2017/01/01 - 2022/12/31 Science and Technology Management Instituto de Medicina Molecular, Portugal
Instituto de Medicina Molecular, Portugal
2014/04/01 - 2017/11/16 Researcher (Research) Instituto de Medicina Molecular, Portugal
2012/03/01 - 2014/03/31 Researcher (Research) Universidade do Porto Laboratorio de Engenharia de Processos Ambiente Biotecnologia e Energia, Portugal

Others

Category
Host institution 		Employer
2023/01/01 - Current CEO / Executive Director Associação AccelBio, Portugal
Outputs

Publications

Journal article
  1. Gomes, Bárbara. "25-Hydroxycholesterol Effect on Membrane Structure and Mechanical Properties". International Journal of Molecular Sciences (2021):
    10.3390/ijms22052574
  2. Gomes, Bárbara. "Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells". (2019): http://dx.doi.org/10.1021/acsinfecdis.8b00321.
    10.1021/acsinfecdis.8b00321
  3. Gomes B; Gonçalves S; Disalvo A; Hollmann A; Santos NC. "Effect of 25-hydroxycholesterol in viral membrane fusion: Insights on HIV inhibition.". Biochimica et biophysica acta (2018): http://europepmc.org/abstract/med/29408450.
    10.1016/j.bbamem.2018.02.001
  4. Gomes B; Augusto MT; Felício MR; Hollmann A; Franco OL; Gonçalves S; Santos NC. "Designing improved active peptides for therapeutic approaches against infectious diseases.". Biotechnology advances (2018): http://europepmc.org/abstract/med/29330093.
    10.1016/j.biotechadv.2018.01.004
  5. Gomes, Bárbara. "Biophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol". Molecules (2017): http://www.mdpi.com/1420-3049/22/11/1869.
    10.3390/molecules22111869
  6. Loureiro JA; Gomes B; Fricker G; Coelho MA; Rocha S; Pereira MC. "Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.". (2016): http://europepmc.org/abstract/med/27131092.
    10.1016/j.colsurfb.2016.04.041
  7. Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S. "Immunoliposomes doubly targeted to transferrin receptor and to a-synuclein.". (2015): http://europepmc.org/abstract/med/28031922.
    10.4155/fso.15.71
  8. Loureiro JA; Gomes B; Fricker G; Cardoso I; Ribeiro CA; Gaiteiro C; Coelho MA; Pereira Mdo C; Rocha S. "Dual ligand immunoliposomes for drug delivery to the brain.". (2015): http://europepmc.org/abstract/med/26204501.
    10.1016/j.colsurfb.2015.06.067
  9. Ramalho MJ; Loureiro JA; Gomes B; Frasco MF; Coelho MA; Pereira MC. "PLGA nanoparticles as a platform for vitamin D-based cancer therapy.". (2015): http://europepmc.org/abstract/med/26199834.
    10.3762/bjnano.6.135
  10. Gomes B; Loureiro JA; Coelho MA; Pereira Mdo C. "The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease.". (2015): http://europepmc.org/abstract/med/25633120.
    10.2174/1381612821666150130120358
  11. Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S. "Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.". (2014): http://europepmc.org/abstract/med/24827845.
    10.2217/nnm.14.27
Activities

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2019/01/01 - 2019/05/31 “Professionals at the Interface of Science: Envisioning Horizon Europe” - 3rd Annual PIC Meeting (Plataforma de Interface à Ciência) (2019/05/10 - 2019/05/10)
Meeting (Member of the Organising Committee)
2018/06/01 - 2018/12/30 iMM Summit is a networking event that wants to match scientific and research capabilities with market needs. Industry will have the opportunity to learn more about the exciting science performed at iMM, as well as its preclinical and clinical research capacity. The iMM research community will be exposed to market trends and partnering opportunities offered by industry. During two days iMM scientists and entrepreneurs, high-level industry representatives and policy makers will meet to share ideas and shape the future of healthcare. (2018/11/16 - 2018/11/17)
Meeting (Co-organisor)
Distinctions

Award

2020 SPBf Young Biophysicist 2020 prize
Sociedade Portuguesa de Biofísica, Portugal
2017 Winner of the Young Investigator Poster Competition
2017 APS Travel Award Grant
2016 PROLAB
American Society of Biochemistry and Molecular Biology, United States
2016 International Travel Award
Biophysical Society, United States

Title

2020 Participant in the first cohort of the Women Leadership Programme
European Innovation Council, Belgium